[1]
Zakir, A.A. and Mohd Siddique, M.U. 2022. #165 Design and synthesis of allosteric fourth-generation EGFR tyrosine kinase triple mutant selective inhibitors for the treatment of non-small cell lung cancer. Journal of Pharmaceutical Chemistry. 8, Supplement (Jul. 2022).